BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 33492425)

  • 1. Overdiagnosis in urologic cancer : For World Journal of Urology Symposium on active surveillance in prostate and renal cancer.
    Klotz L
    World J Urol; 2022 Jan; 40(1):1-8. PubMed ID: 33492425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer overdiagnosis and overtreatment.
    Klotz L
    Curr Opin Urol; 2012 May; 22(3):203-9. PubMed ID: 22472510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overdiagnosis and overtreatment of prostate cancer.
    Loeb S; Bjurlin MA; Nicholson J; Tammela TL; Penson DF; Carter HB; Carroll P; Etzioni R
    Eur Urol; 2014 Jun; 65(6):1046-55. PubMed ID: 24439788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overdiagnosis of prostate cancer.
    Sandhu GS; Andriole GL
    J Natl Cancer Inst Monogr; 2012 Dec; 2012(45):146-51. PubMed ID: 23271765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Harms of Overdiagnosis and Overtreatment in Patients with Small Renal Masses: A Mini-review.
    Sohlberg EM; Metzner TJ; Leppert JT
    Eur Urol Focus; 2019 Nov; 5(6):943-945. PubMed ID: 30905599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overdiagnosis: An Understudied Issue in Hepatocellular Carcinoma Surveillance.
    Rich NE; Parikh ND; Singal AG
    Semin Liver Dis; 2017 Nov; 37(4):296-304. PubMed ID: 29272892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structured Population-based Prostate-specific Antigen Screening for Prostate Cancer: The European Association of Urology Position in 2019.
    Gandaglia G; Albers P; Abrahamsson PA; Briganti A; Catto JWF; Chapple CR; Montorsi F; Mottet N; Roobol MJ; Sønksen J; Wirth M; van Poppel H
    Eur Urol; 2019 Aug; 76(2):142-150. PubMed ID: 31092338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate cancer overdiagnosis and overtreatment.
    Klotz L
    Curr Opin Endocrinol Diabetes Obes; 2013 Jun; 20(3):204-9. PubMed ID: 23609043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individualized estimates of overdiagnosis in screen-detected prostate cancer.
    Gulati R; Inoue LY; Gore JL; Katcher J; Etzioni R
    J Natl Cancer Inst; 2014 Feb; 106(2):djt367. PubMed ID: 24399850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Terminology Change for Small Low-Risk Papillary Thyroid Cancer As a Response to Overtreatment: Results from Three Australian Community Juries.
    Shih P; Nickel B; Degeling C; Thomas R; Brito JP; McLeod DSA; McCaffery K; Carter SM
    Thyroid; 2021 Jul; 31(7):1067-1075. PubMed ID: 33238815
    [No Abstract]   [Full Text] [Related]  

  • 12. Changing Trends in Surgical Management of Prostate Cancer: The End of Overtreatment?
    Huland H; Graefen M
    Eur Urol; 2015 Aug; 68(2):175-8. PubMed ID: 25736732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LOW RISK PROSTATE CANCER: ACTIVE TREATMENT OR ACTIVE SURVEILLANCE?
    Tomašković I
    Acta Clin Croat; 2015 Sep; 54(3):337-44. PubMed ID: 26666105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast, prostate, and thyroid cancer screening tests and overdiagnosis.
    Jung M
    Curr Probl Cancer; 2017; 41(1):71-79. PubMed ID: 28104314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for prostate cancer.
    Ilic D; Neuberger MM; Djulbegovic M; Dahm P
    Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD004720. PubMed ID: 23440794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A European Model for an Organised Risk-stratified Early Detection Programme for Prostate Cancer.
    Van Poppel H; Hogenhout R; Albers P; van den Bergh RCN; Barentsz JO; Roobol MJ
    Eur Urol Oncol; 2021 Oct; 4(5):731-739. PubMed ID: 34364829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining the threshold for significant versus insignificant prostate cancer.
    Van der Kwast TH; Roobol MJ
    Nat Rev Urol; 2013 Aug; 10(8):473-82. PubMed ID: 23712205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends.
    Etzioni R; Penson DF; Legler JM; di Tommaso D; Boer R; Gann PH; Feuer EJ
    J Natl Cancer Inst; 2002 Jul; 94(13):981-90. PubMed ID: 12096083
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.